Patient Guide: A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • ✓ Get matched to the right study location for you
  • ✓ Connect directly with study coordinators at 59 participating sites
  • ✓ Understand eligibility with our simplified screening tool
  • ✓ Free service - we're here to help you access clinical research
Trial ID: NCTNCT06346067
Status: 🟢 Enrolling Now
Condition: Advanced or Metastatic NRAS-mutant Melanoma
Phase: PHASE3

Find a Study Location Near You

This study is available at 59 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • • Phoenix, Arizona
  • • San Francisco, California
  • • Englewood, Colorado
  • • And 56 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2) - Join Clinical Trial NCTNCT06346067

How to Join This Clinical Trial - NCTNCT06346067

Learn how to participate in this PHASE3 trial studying an investigational therapy for Advanced or Metastatic NRAS-mutant Melanoma. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Advanced or Metastatic NRAS-mutant Melanoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Advanced or Metastatic NRAS-mutant Melanoma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06346067 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 59 locations. Find a study site near you:

Clinical Research Site

Phoenix, Arizona 85054 - United States

Status: RECRUITING

Clinical Research Site

San Francisco, California 94143 - United States

Status: RECRUITING

Clinical Research Site

Englewood, Colorado 80113 - United States

Status: RECRUITING

Clinical Research Site

Jacksonville, Florida 70121 - United States

Status: RECRUITING

Clinical Research Site

Miami, Florida 33136 - United States

Status: RECRUITING

Clinical Research Site

Kansas City, Kansas 66205 - United States

Status: RECRUITING

Clinical Research Site

Jefferson, Louisiana 70121 - United States

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Boston, Massachusetts 02114 - United States

Status: RECRUITING

Clinical Research Site

Detroit, Michigan 48201 - United States

Status: RECRUITING

Clinical Research Site

Rochester, Minnesota 70121 - United States

Status: RECRUITING

And 49 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Advanced or Metastatic NRAS-mutant Melanoma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai as Your Clinical Trial Matching Service

Quri.ai is a free clinical trial matching service that helps patients connect with research sites. We make it easier to:

  • Find clinical trials that match your condition
  • Get matched to the right study location near you
  • Connect directly with study coordinators
  • Understand if you qualify with simplified eligibility screening
  • Navigate the enrollment process with personalized support
  • Access new treatments through clinical research participation